Grupo Moehs.
Referente a nivel mundial
En un mercado de rápido crecimiento y alta competitividad, Grupo Moehs ha progresado convirtiéndose en una de las principales compañías a nivel mundial.
Los factores clave que confirman esta trayectoria son:
Consolidación de una amplia gama de productos con diferentes actividades terapéuticas: desde mucolíticos hasta ß-blocantes.
Ampliación continua de nuestra lista de APIs.
Óptimo equilibrio entre costes y servicios ofrecidos.
Capacidad de comprensión de las necesidades transmitidas por los clientes para trasladarlas a nuestra gama.
Soporte documental y regulatorio.
Lista de Productos
| Nombre producto | Cas nº | Categoría terapéutica | Datos Regulatorios | Farmacopeas | Planta de producción |
|---|---|---|---|---|---|
| ACEBUTOLOL HCL | 34381-68-5 | Antianginal – Antihypertensive – Antiarrhythmic | CEP, EDMF, USDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CANTABRA & COPRIMA |
| AMANTADINE HCl | 665-66-7 | Antiviral -Antiparkinsonian | CEP, EDMF USDMF | Ph. Eur. 11 USP-NF-2022, JP 16 | M. CATALANA |
| AMANTADINE SULPHATE | 31377-23-8 | Antiviral -Antiparkinsonian | EDMF | DAC 2011 | CANTABRA |
| AMLODIPINE BESILATE | 111470-99-6 | Antianginal – Antihypertensive | CEP, EDMF, USDMF, JDMF, KDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA |
| ARTICAINE HCI or CARTICAINE HCI | 23964-57-0 | Local Anesthetic- Antiarrhythmic | CEP, EDMF, USDMF | Ph. Eur. 11, USP-NF-2022 | BENECHIM |
| BISOPROLOL FUMARATE | 104344-23-2 | Antihypertensive | CEP, EDMF, USDMF, JDMF, ND | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA |
| BUPIVACAINE HYDROCHLORIDE | 73360-54-0 | Local Anesthetic-Antiarrhythmic | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CATALANA |
| CARBOCYSTEINE | 638-23-3 | Mucolytic | CEP, EDMF, JDMF | Ph. Eur. 11, JP 16 | M. CATALANA & M. BCN |
| CARBOCYSTEINE LYSINE SALT | 151756-26-2 | Mucolytic | EDMF | in house | M. BCN |
| CARVEDILOL | 72956-09-3 | Antihypertensive | CEP, EDMF, USDMF, JDMF, KDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CATALANA & COPRIMA |
| CELIPROLOL HCI | 57470-78-7 | Antianginal- Antihypertensive | CEP, EDMF, JDMF | Ph. Eur. 11 | COPRIMA |
| CHOLINE FENOFIBRATE | 856676-23-8 | Antihyperlipidemic | USDMF | In house | COPRIMA |
| DEXMEDETOMIDINE HCL | 145108-58-3 | Sedative | DMF | USP-NF-2022 | NORCHIM & IBERICA |
| DULOXETINE HCL | 136434-34-9 | Antidepressant | CEP, EDMF, USDMF, KDMF | Ph. Eur. 11, USP-NF-2022 | M. CANTABRA & M. BCN |
| FENOFIBRATE | 49562-28-9 | Antihyperlipidemic | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | COPRIMA |
| LIDOCAINE BASE | 137-58-06 | Local Anesthetic-Antiarrhythmic | CEP, EDMF,JDMF, USDMF | Ph. Eur. 11, USP-NF-2022 | M. CATALANA &. BCN |
| LIDOCAINE HCI | 6108-05-0 | Local Anesthetic-Antiarrhythmic | CEP, EDMF, USDMF, JDMF | Ph. Eur. 11, USP-NF-2022 | M. CATALANA & M. BCN |
| MAGNESIUM LACTAE DIHYDRATE | 18917-93-6 | Magnesium Supplement | EDMF, ND | Ph. Eur. 11 | CANTABRA |
| MEBEVERINE HCl | 2753-45-9 | Antispasmodic | EDMF, ND | Ph. Eur 11, BP 2013 | BENECHIM |
| MEPIVACAINE HYDROCHLORIDE | 1722-62-9 | Local Anesthetic-Antiarrhythmic | CEP, EDMF, USDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA |
| METOPROLOL SUCCINATE | 98418-47-4 | Antihypertensive | CEP, EDMF USDMF | Ph. Eur. 11 USP-NF-2022 | CATALANA & BENECHIM |
| METOPROLOL TARTRATE | 56392-17-7 | Antihypertensive | CEP, EDMF USDMF, JDMF | Ph. Eur. 11 USP-NF-2022, JP 16 | M. CATALANA |
| N-ACETYLCYSTEINE | 616-91-1 | Mucolytic | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CATALANA |
| NIFEDIPINE | 21829-25-4 | Antianginal-Antihypertensive | CEP, EDMF, USDMF, JDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA |
| NIFUROXAZIDE | 965-52-6 | Antidiarrheal | EDMF, ND | Ph. Eur. 11 | COPRIMA |
| PANTOPRAZOLE SODIUM | 164579-32-2 | Antiulcerative | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CANTABRA |
| PRILOCAINE BASE | 721-50-6 | Local Anesthetic | EDMF, USDMF | Ph. Eur. 11, USP-NF-2022 | BENECHIM |
| PRILOCAINE HCL | 1786-81-8 | Local Anesthetic-Antiarrhythmic | EDMF, USDMF | Ph. Eur. 11, USP-NF-2022 | BENECHIM |
| PYRANTEL EMBONATE | 22204-24-6 | Anthelmintic | EVMF, USVMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA & COPRIMA |
| QUETIAPINE FUMARATE | 111974-72-2 | Antipsychotic | CEP, EDMF, USDMF, KDMF | Ph. Eur. 11, USP-NF-2022 | M. CANTABRA |
| RABEPRAZOLE SODIUM | 117976-90-6 | Antiulcerative | CEP, EDMF, USDMF, ND | Ph. Eur. 11 | M. CATALANA |
| ROPIVACAINE HCL | 132112-35-7 | Local Anesthetic | USDMF | Ph. Eur. 11, USP-NF-2022 | BENECHIM |
| SITAGLIPTIN HCL | 862156-92-1 | Antidiabetic | EDMF | in house | BENECHIM |
| SOTALOL HCL | 959-24-0 | Antianginal-Antihypertensive | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CATALANA |
| SUMATRIPTAN BASE | 103628-46-2 | Antimigraine | USDMF | USP-NF-2022 | M. CATALANA |
| SUMATRIPTAN SUCCINATE | 103628-48-4 | Antimigraine | EDMF, USDMF, JDMF | Ph. Eur. 11, USP-NF-2022 | M. CATALANA |
| TRIAMTERENE | 396-01-0 | Diuretic | CEP, EDMF, USDMF, JDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA |
| TRIMEBUTINE BASE | 39133-31-8 | Antispasmodic | EDMF | in house | CANTABRA |
| TRIMEBUTINE MALEATE | 34140-59-5 | Antispasmodic | CEP, EDMF, ND | Ph. Eur. 11, JP 16 | M. CATALANA & M. CANTABRA |
| VENLAFAXINE HCI | 99300-78-4 | Antidepressant | CEP, EDMF, USDMF | Ph. Eur. 11, USP-NF-2022 | M .CANTABRA |
| VILDAGLIPTIN | 274901-16-5 | Antidiabetic | DMF | Ph. Eur. 11 | BCN |
Productos en fase final de desarrollo
| Nombre del producto | CAS N° | Categoría terapéutica | Disponibilidad | Datos regulatorios | Farmacopea |
|---|---|---|---|---|---|
| EDOXABAN (**) | 1229194-11-9 | Oral anticoagulant | Validation batches | DMF | |
| EMPAGLIFLOZIN (**) | 864070-44-0 | Antidiabetic | Validation batches | DMF | |
| LEVOBUPIVACAINE HCL (**) | 27262-48-2 | Local Anesthetic-Antiarrhythmic | Validation batches | TP | |
| REMIMAZOLAM (**) | 308242-62-8 | Sedative | Laboratory batches | US-DMF | |
| RIVAROXABAN (**) | 366789-02-8 | Antibleeding agent | Validation batches | DMF | Ph. Eur. |
| SITAGLIPTIN HCL (**) | 862156-92-1 | Antidiabetic | Validation batches | DMF | |
| SITAGLIPTIN PHOSPHATE (**) | 654671-77-9 | Antidiabetic | Validation batches | DMF | USP / Ph. Eur. |
| VILDAGLIPTIN (**) | 274901-16-5 | Antidiabetic | Validation batches | DMF |
(**) Moehs está trabajando en este compuesto con fines experimentales, dirigidos exclusivamente a obtener autorizaciones de mercado de los medicamentos genéricos de nuestros clientes. No tenemos la intención de realizar ninguna actividad contra ninguna protección de patente válida, así como tampoco nos haremos cargo de acciones de terceros realizadas con el compuesto proporcionado y sin nuestro conocimiento contra esta protección.
Productos en etapa inicial de desarrollo
| Product Name | CAS N° | Therapeutic Category | Additional Information | DMF / TP |
|---|---|---|---|---|
| ABROCITINIB (**) | 1622902-68-4 | Atopic Dermatitis | Laboratory batches | TP |
| DARIDOREXANT (**) | 1792993-84-0 | Insomnia | Laboratory batches | |
| EDOXABAN (**) | 1229194-11-9 | Oral anticoagulant | Validation batches | DMF |
| ELAGOLIX (**) | 832720-36-2 | Uterine Fibroids, Endometriosis pain | Validation batches | TP |
| EMPAGLIFLOZIN (**) | 864070-44-0 | Antidiabetic | Validation batches | DMF |
| FEZOLINETANT(**) | 1629229-37-3 | Menopausal Vasomotor symptoms | Laboratory batches | |
| LASMIDITAN SUCCINATE (**) | 439239-92-6 | Antimigraine | Kilo - Lab batches | DMF |
| LEMBOREXANT (**) | 1369764-02-2 | Insomnia treatment | Laboratory batches | TP |
| LINZAGOLIX(**) | 935283-04-8 | Uterine Fibroids. Endometriosis | Laboratory batches | |
| LEVOBUPIVACAINE HCL | 27262-48-2 | Local Anesthetic-Antiarrhythmic | Validation batches | DMF |
| MAVACAMTEN (**) | 1642288-47-8 | Hypertrophic Cardiomyopathy | Kilo-lab batches | DMF |
| NORADRENALINE TARTRARE | 103341-18-0 | Cardiovascular | Kilo - lab batches | TP |
| RELUGOLIX (**) | 737789-87-6 | Advanced prostate cancer. Uterine Fibroids, endometriosis | Kilo-lab batches | DMF |
| REMIMAZOLAM BESYLATE (**) | 308242-62-8 | Sedation General Aneshhesia | Validation batches | US-DMF |
| RIMEGEPANT SULFATE (**) | 1374024-48-2 | Acute migraine | Kilo - lab batches | DMF |
| TAPINAROF (**) | 115781-08-3 | Psoriasis | Laboratory batches | |
| RIVAROXABAN (**) | 366789-02-8 | Oral anticoagulant | Validation batches | DMF |
| SITAGLIPTIN PHOSPHATE (**) | 654671-77-9 | Antidiabetic | Validation batches | DMF |
| TIRBANIBULIN (**) | 897016-82-9 | Actinic Keratosis | Kilo - Lab batches | DMF |
| ZAVEGEPANT (**) | 1414976-20-7 | Acute migraine | laboratory batches | |
| VERICIGUAT (**) | 1350653-20-1 | Heart Failure | Kilo - lab batches | DMF |
Nuevos Productos en evaluación
| Product Name | CAS N° | Brand Name | Therapeutic Category | Galenic Form |
|---|---|---|---|---|
| MAVACAMTEN (**) | 1642288-47-8 | Cardiovascular | capsules | |
| VERICIGUAT (**) | 1350653-20-1 | Antihypertensive | tablets |
